Abstract
The 5q-chromosome is found in a spectrum of malignant myeloid disorders (1). The 5q deletion is the most commonly reported deletion in the myelodysplastic syndromes (MDS) and is found in 10–l5% of patients (1). The 5q-chromosome occurs as a sole karyotypic abnormality in the distinct myelodysplastic syndrome the 5q-syndrome (2). The 5q-chromosome is also observed frequently in therapy related MDS and acute myeloid leukemia (AML) where it is typically reported together with other karyotypic abnormalities (3). The 5q deletton is interstitial and the breakpoints are variable. The breakpoints most frequently reported are 5q12-q14 (proximal) and 5q3l-q33 (distal) (4). The most commonly reported 5q deletion is the del (5)(q13q33) (5). There appears to be no difference in the pattern of 5q deletion breakpoints between MDS and AML (4, 5).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Van den Berghe, H, Vermaelen, K., Mecucci, C., Barbieri, D., and Tricot, G. (1985) The 5q-anomaly. Cancer Genet Cytogenet 17, 189–255.
Van den Berghe, H., Cassiman, J. J, David, G., Fryns, J. P., Michaux, J. L, and Sokal, G. (1974) Distinct haematologtcal disorder with deletion of the long arm of No. 5 chromosome Nature 251, 437–438
Le Beau, M M., Albain, K. S., Larson, R. A., Vardiman, J W, Davis, E. M., Blough, R. R., Golomb, H. M., and Rowley, J. D. (1986) Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute non-lymphocytic leukemia further evidence for characteristic abnormalities of chromosomes nos 5 and 7 J Clin Oncol 4, 325–345
Mitelman, F., Manolova, Y., Manolova, G., Billstom, R., Heims, S., Kristofferson, U, and Mandahl, N. (1986) Analysis of the 5q marker chromosome in refractory anemia Hereditas 105, 49–54.
Pedersen, B. and Jensen, I M (1991) Clinical and prognostic implications of chromosome 5q deletions. 96 high resolution studied patients Leukemia 5, 566–573.
Le Beau, M. M., Espinosa, R., Neuman, W. L., Stock, W., Roulston, D., Larson, R A., Keinanen, M., and Westbrook, C. A (1993) Cytogenetic and molecular delieation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl. Acad Sci USA 90, 5484–5488.
Boultwood, J., Fidler, C., Lewis, S., Kelly, S, Sheridan, H., Littlewood, T J., Buckle, V. J., and Wainscoat, J. S. (1994) Molecular Mapping of uncharacter-istically small 5q deletions in two patients with the 5q-syndrome. delineation of the critical region on 5q and identification of a 5q-breakpoint. Genomics 19, 425–432.
Willman, C. L, Sever, C E., Pallavicini, M. G., Harada, H., Tanaka, N., Slovak, M.L., Yamamoto, H., Harada, K., Meeker, T C, List, A. F., et al (1993) Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259, 968–71.
Boultwood, J., Lewis, S., and Wainscoat, J S. (1994) The 5q-syndrome Blood 84, 3253.
Boyum, A. (1986) Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combinmg centrifugation and sedimentation at l g Stand J Clin Lab Invest 97, 77(suppl).
Kaplan, M. E. and Clark, C J. (1974) An improved rosetting assay for detection of human T-lymphocytes J Immunol Methods 5, 131.
Mullis, K. B. and Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155, 335–350.
Weber, J. L. and May, P. E. (1989) Abundant class of human DNA polymorphisms which can be typed usmg the polymerase chain reaction. Am J Hum Genet 81, 388–396.
Nagarajan, L., Zavadil, J., Claxton, D., Lu, X., Fairman, J., Warrington, J., Wasmuth, J. J., Chinault, A. C., Sever, C. E., Slovak, M. L., Willman, C. L., and Deisseroth, A. B. (1994) Consistent Loss of the D5S89 locus mapping telomeric to the mterleukin gene cluster and centromeric to EGR-1 in patients with 5q-chromosome. Blood 83, 199–208.
De Qi, Xu, Guilhot, S., and Galibert, F. (1985) Restriction fragment length polymorphism of the human c-fms gene. PNAS 82, 2862–2865
Heighway, J., Hoban, P. R., and Wyllie, A. H. (1991) Sspl polymorphism in sequence encoding 3′ untranslated region of the APC gene. Nucl. Acids Res. 19, 6966.
Weber, J. L., Polymeropoulos, M. H., May, P. E., Kwitek, A. E., Xiao, H., McPherson, J D., and Wasmuth, J J (1991) Genomics 11, 695–700.
Boultwood, J., Fidler, C., Lewis, S., MacCarthy, A., Sheridan, H., Littlewood, T. J., Buckle, V. J, and Wainscoat, J. S. (1993) Allelic loss of IRFl in myelodysplasia and acute myeloid leukemia: Retention of IRFl on the 5q-chromosome in some patients with the 5q-syndrome. Blood 2611–2616
Boultwood, J., Rack, K., Kelly, S., Madden, J., Sakoguchi, A Y., Wang, L. M., Oscier, D. G., Buckle, V. J., and Wainscoat, J. S (1991) Loss of both FMS alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc Natl. Acad. Sci USA 88. 6176.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Boultwood, J. (1996). Molecular Diagnosis of the 5q Deletion in Malignant Myeloid Disorders. In: Cotter, F.E. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine™, vol 6. Humana Press. https://doi.org/10.1385/0-89603-341-4:91
Download citation
DOI: https://doi.org/10.1385/0-89603-341-4:91
Publisher Name: Humana Press
Print ISBN: 978-0-89603-341-2
Online ISBN: 978-1-59259-590-7
eBook Packages: Springer Protocols